At our September Board meeting in Indianapolis and at subsequent meetings thereafter, the Board took several bold steps that I am satisfied will ensure an active and financially solvent ITA... Read more

With the recent efforts of the Centers for Disease Control to gather info from the pub- lic on ways to reduce UV exposure, I have to give our adversaries grudging credit. They could write th... Read more

Everyone has heard the old saying, “Just because you’re paranoid doesn’t mean they’re not out to get you.” Just look at what our friends in Washington have brought us in the past three years... Read more

On August 7, we submitted detailed comments to the FDA in response to the Administrative Order reclassifying ultraviolet lamps for tanning to a Class II Medical Device.  Lawyers at the firm... Read more

Joined by a group of industry leaders, the ITA Board members were in Washington, DC in May for the semi-annual day on Capitol Hill. On May 22, our team hit the ground running, hosting a 7:30... Read more

The ITA hosted an Open Board Meeting in Washington, D.C. on May 21, in conjunction with the semiannual day on Capitol Hill. Needless to say, the top item on the agenda was discussion of the... Read more

I’m taking this opportunity to call to your attention the work and contributions of a truly unselfish ITA Board member, Jim Shepherd, owner of Sperti Sunlamps in Crescent Springs, KY. Many o... Read more

It has been a busy and difficult year for the industry in the state legislative fights, with approximately 46 bills introduced in 30 different states. Early in the session, New Jersey follow... Read more

Over three years have passed since the FDA held its infamous, day-long advisory committee meeting to discuss reclassifying sunbeds and sunlamps and to examine the need to add industry-killin... Read more

Our Opponents Continue to Raise the Stakes Anyone paying attention to the media and state and Federal issues must have noticed a steady increase in the frequency and intensity of the attacks... Read more